[Clinical significance of the feto-placental unit during pregnancy and parturition]. 1986

T Nakayama

Theoretical basis of measurement of estriol during pregnancy. It was clarified that the feto (adrenal and liver)-placental unit plays an important role in the biosynthesis of estriol during pregnancy. The theoretical basis of the usefulness of estriol estimation in maternal urine as the indicator of fetal viability is therefore established, and a simplified estriol assay (LAIR-3 minutes method) was developed. As to the steroid values in the amniotic fluid during pregnancy, high level of progesterone (P4) in the first trimester and prominent rises of DHA-S and estriol values near term were shown. Furthermore, transference of amniotic DHA-S to the mother through the amniotic membrane was demonstrated by the in vivo study using deuterium labeled DHA-S given in the amniotic fluid. In vivo study using deuterated pregnenolone sulfate (P5-S) given in the maternal circulation demonstrated that maternal P5-S was partially used as the precursor of placental P4. Therefore, it is suggested that the precursor of placental P4 is mainly derived from the feto-placental side rather than the maternal one. Changes of steroidal environment near term. Steroid hormone assay by gas chromatography mass-spectrometry using deuterium labeled compound as internal standard was developed, and (fetal adrenal) steroid values in maternal blood were measured. DHA-S, 16 alpha-OH- DHA-S and estriol values increase in the prepain and labor period and P4 and 20 alpha-OH-P4 values decrease during labor. In vivo study using deuterium labeled DHA-S given to the fetal side in the perinatal period demonstrated that DHA-S originated from fetal adrenal transferred to the mother through placenta without being subjected to the aromatisation. The elevation of uterine sensitivity to oxytocin in the perinatal period is closely related to both the increases of DHA-S and estriol levels, and the decrease of P4 values in the maternal blood. As to the hormonal factors of hypothalamo-posterior pituitary system, the levels of estrogen stimulated neurophysin (ESN) and oxytocin in the maternal blood elevated parallel with the increase of estrogen level in the prepain period. The administration of DHA-S (100mg, twice a week) in the perinatal period accelerate the maturation of uterine cervix with concomitant augmentation of DHA-S concentration and increased proline hydroxylase activity in the cervical tissue.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D007028 Hypothalamic Hormones Peptide hormones produced by NEURONS of various regions in the HYPOTHALAMUS. They are released into the pituitary portal circulation to stimulate or inhibit PITUITARY GLAND functions. VASOPRESSIN and OXYTOCIN, though produced in the hypothalamus, are not included here for they are transported down the AXONS to the POSTERIOR LOBE OF PITUITARY before being released into the portal circulation. Hypothalamic Pituitary-Regulating Hormones,Hypothalamic Pituitary-Regulating Peptides,Hormones, Hypothalamic,Hormones, Hypothalamic Pituitary-Regulating,Hypothalamic Pituitary Regulating Hormones,Hypothalamic Pituitary Regulating Peptides,Peptides, Hypothalamic Pituitary-Regulating,Pituitary-Regulating Hormones, Hypothalamic,Pituitary-Regulating Peptides, Hypothalamic
D007743 Labor, Obstetric The repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix (CERVIX UTERI). Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced (LABOR, INDUCED). Obstetric Labor
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D010907 Pituitary Hormones Hormones secreted by the PITUITARY GLAND including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (NEUROTRANSMITTERS) or neuroendocrine signals (HYPOTHALAMIC HORMONES) from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS. Hormones, Pituitary
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011284 Pregnenolone A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS. 5-Pregnen-3-beta-ol-20-one,5 Pregnen 3 beta ol 20 one
D004964 Estriol A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol. (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,16-alpha-Hydroxy-Estradiol,16alpha,17beta-Estriol,16beta-Hydroxy-Estradiol,Epiestriol,Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol,Ovestin,16 alpha Hydroxy Estradiol,16alpha,17beta Estriol,16beta Hydroxy Estradiol
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal

Related Publications

T Nakayama
January 1977, Panminerva medica,
T Nakayama
January 1994, Experimental and clinical endocrinology,
T Nakayama
April 2000, Early pregnancy,
T Nakayama
May 1971, Horumon to rinsho. Clinical endocrinology,
T Nakayama
December 1971, Nihon Sanka Fujinka Gakkai zasshi,
T Nakayama
June 1977, The Ceylon medical journal,
Copied contents to your clipboard!